Vivo Bio Tech Limited is an India-based company, which is a comprehensive preclinical clinical research organization (CRO) serving pharmaceutical and biotech firms. It operates in the biotechnology segment. It provides integrated discovery, development & regulatory services to pharmaceutical, agrochemical, industrial chemical, vaccines, nutraceutical & medical device companies. The Company's services include in-Vivo and in-Vitro toxicity studies, pharmacological investigations, pharmacokinetic, toxicokinetic studies, genotoxicity screening and analytical services. It screens and assesses molecules for diverse pharmacological properties. In oncology, it designs syngeneic/xenograft models for anti-cancer agent evaluation. It customizes in-Vivo DMPK studies for rodent and non-rodent models to profile drug candidates. It provides both regulatory and non-regulatory IND-enabling preclinical development services. As of 25 May 2026, VIVO BIO TECH LTD. share price is ₹28.30. The stock opened at ₹27.20, compared to its previous close of ₹26.49. During today's trading session, VIVO BIO TECH LTD. share price moved in the range of ₹26.53 to ₹28.70, with an average price of ₹27.62 for the day. Looking at its last 52-week, the stock has touched a low of ₹26.53 and a high of ₹28.70.
The market capitalization of VIVO BIO TECH LTD. is ₹59 Crs, with a P/E ratio of 13.0 and a dividend yield of 0.00%.